-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
The approval of the PTCL indication is based on data from a Phase 2b study of 55 aggressive PTCL patients from Japan and South Korea
Dr.
Dr.
Dr.
About Chidamide
Chidamide is a new molecular entity drug with global patent protection discovered exclusively by Microchip Biosciences.
Chidamide has obtained invention patents in nearly 30 countries and regions around the world.
About Microchip
Microchip Bio is a modern biomedical company founded in 2001 by a senior team returning from the United States
Relying on the self-created internationally advanced "integrated drug discovery and early evaluation platform based on chemical genomics", Microchip Biosciences has been involved in five major diseases including tumors, metabolic diseases, autoimmune diseases, central nervous diseases and antiviral diseases.
At present, Microchip has a wholly-owned subsidiary of Shenzhen Headquarters/R&D Center/GMP production base, Shenzhen Chips Pharmaceutical Co.